ClinicalTrials.Veeva

Menu

Efficacy and Tolerance Study on the Use of the In-exsufflator in the Hospitalized Elderly (INEXPA)

U

University Hospital, Clermont-Ferrand

Status

Completed

Conditions

Airway Obstruction

Treatments

Device: Mechanical In-Exsufflator (MI-E)

Study type

Observational

Funder types

Other

Identifiers

NCT05090696
RNI 2021 ESTENNE (INEXPA)
2021-A00891-40 (Other Identifier)

Details and patient eligibility

About

The mechanical in-exsufflator (MI-E) is a medical device used to facilitate coughing when the patients' cough is not efficient. Studies have shown positive results in helping airway clearance in children and adults with neuromuscular disorders however there is lack of evidence in older populations. This study's aim is to evaluate the feasibility of the MI-E in older adults. The hypothesis is that the use of MI-E in older adults is feasible.

Full description

Background: One of the most frequent reasons for hospital admission of older adults are respiratory disorders. Physiological aging processes decrease respiratory muscle strength and can reduce the efficacity of cough. The mechanical in-exsufflator (MI-E) is a medical device used to help coughing. Studies have shown positive results in helping airway clearance in children and adults with neuromuscular pathologies however there is lack of evidence in older populations. This study's aim is to evaluate the feasibility of the MI-E in older adults. The hypothesis is that the use of MI-E in older adults is feasible.

Methods: Feasibility will be evaluated by outcomes such as the discomfort of each session (use of a numerical scale of discomfort from 0 to 10) and the relief felt before and after each session (use of a modified Borg scale to quantify dyspnea). Two sessions a day of MI-E will be done for a total of four sessions. Furthermore, other outcomes shall be used, before and after each session, such as vital signs (heart and respiratory rate, blood pressure and oxygen saturation), auscultation as well as the measure of cough peak flow.

Discussion: The protocol of this study is the first to evaluate the use of MI-E in hospitalized older adults by the measure of discomfort and relief. In regard to literature on the use of MI-E in patients suffering from neuromuscular pathologies and on the effects of aging on the respiratory system, the hypothesis of the study seems justified. On top of bringing physical benefits to the patient, the study will pave the way for other randomized controlled studies.

Enrollment

15 patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient hospitalize in Intensive Care Unit or Pulmonary Unit,
  • having airway clearance problem associated with mucus hypersecretion,
  • peak expiratory flow (PEF) <280 l/min,
  • medical indication for respiratory physical therapy.

Exclusion criteria

  • contraindication to use of MI-E device (ex. bronchospasm, immediate follow-up to surgery of airway system, chest or abdominal region, untreated pneumothorax, hemodynamic failure, etc.),
  • refuse to participate,
  • pregnant,
  • breastfeeding,
  • insufficient cognitive status.

Trial design

15 participants in 1 patient group

One group only
Description:
Participants recruited from patients hospitalized in intensive care units and pulmonary unit of the University Hospital of Clermont-Ferrand, France.
Treatment:
Device: Mechanical In-Exsufflator (MI-E)

Trial contacts and locations

1

Loading...

Central trial contact

Lise Laclautre

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems